The efficacy of the rituximab-containing rescue-regimen for severe hemophilia A inhibitor children who relapsed following successful immune tolerance induction with rituximab in China.

Authors	Zhengping Li, Zekun Li, Jie Sun, Xiaoling Cheng, Guoqing Liu, Wanru Yao, Kun Huang, Di Ai, Zhenping Chen, Gang Li, Yingzi Zhen, Man-Chiu Poon, Runhui Wu
Journal	Thrombosis research (Thromb Res) Vol. 223 Pg. 123-126 (03 2023) ISSN: 1879-2472 [Electronic] United States
PMID	36739806 (Publication Type: Letter)
Chemical References	Rituximab Factor VIII
Topics	Child Humans Rituximab Hemophilia A Factor VIII Immune Tolerance China

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!